Ng STH, Price MJ, Richardson N, Nawaf M, et al. Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes. Diabetes 2024 Nov 21:db230996. doi: 10.2337/db23-0996.
PMID: 39571092